NR

Nirav Ramniklal Mehta

Director Director DIN 10038402
DIN 10038402 First appointment Jan 2023 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jan 2023
Shareholding value Locked Premium profile

About Nirav Ramniklal Mehta

Data last updated:

Nirav Ramniklal Mehta has 3 years in corporate governance. Formerly with 1 company, such as Pyramid Pharma Impex Llp. Engaged in General Business. Contributes to corporate operations.

DIN 10038402
Primary Designation Director
First Appointment 12 Jan 2023
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Designated Partner12 Jan 20232023Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Pyramid Pharma Impex Llp
Premium access

Shareholding and investment profile for Nirav Ramniklal Mehta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nirav Ramniklal Mehta

Nirav Ramniklal Mehta has 3 years in corporate governance. Formerly with 1 company, such as Pyramid Pharma Impex Llp. Engaged in General Business. Contributes to corporate operations.

Nirav Ramniklal Mehta is associated with 0 companies as a director.

Nirav Ramniklal Mehta has expertise in General Business.

Nirav Ramniklal Mehta has 3 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available